Dr. Boehm joined NIST in September 2006 as a policy analyst in the Program Office in the Office of the Director at the National Institute of Standards and Technology. As a policy analyst Dr. Boehm was responsible for providing objective analysis and evaluation to the Director of NIST on a portfolio of issues related to the biological sciences, homeland security, and programs that enhance innovation and competitiveness, in support of NIST strategic planning and budget development. Dr. Boehm came to NIST from the Office of Science and Technology Policy (OSTP), Executive Office of the President, where he was responsible for consultation, analysis, and policy development regarding science and technology related to multiple issues of homeland and national security including the development of medical and non-medical countermeasures against WMD, domestic nuclear defense, engineered threats and emerging infectious diseases, and biological and chemical agent decontamination, nuclear defense and detection, international collaborations on homeland security-related S&T, and a number of other issues. Dr. Boehm originally joined OSTP as a AAAS/NTI Fellow in Global Security, an award that provided him the opportunity to work anywhere within the U.S. government on issues related to biological terrorism. Prior to joining the federal government Dr. Boehm was involved in cancer research at Cornell University, where he led a team of researchers studying the role of the cellular protein tissue transglutaminase in cell survival and tumorigenesis. Dr. Boehm received his Ph.D. in 2000 from the University of Nebraska Medical Center, Eppley Institute for Cancer Research, where he studied the role of receptor tyrosine kinase signaling in cell survival.